Every time Ashton Alexander sees an ad for Georgia Pathways to Coverage, it feels like a “kick in the face.” Alexander tried signing up for Pathways, the state’s limited Medicaid expansion, multiple times and got denied each time, he said, even though he met the qualifying terms because he’s a full-time student. Georgia is one…
Claim denials are a well-documented challenge for healthcare organizations. Denied claims take much longer to pay out than first-time claims, if they get paid at all. Each one means additional hours of rework and follow-up, pulling in extra resources as staff review payer policies and figure out what went wrong. It’s time-consuming and costly. Beyond…
Most people who get their health coverage through the Affordable Care Act say they face sharply higher costs, with many worried they will have to pare back other expenses to cover them, according to a poll released Thursday. Some are uncertain whether they will be able to continue paying their premiums all year. Still, 69%…
In this viewpoint article in the Journal of the International AIDS Society, KFF’s Jennifer Kates and co-authors Brian Honermann and Gregorio Millett of amfAR explore the implications of shifts in the global economic and political environment for the future of PEPFAR, the U.S government’s global HIV program created under President George W. Bush and credited…
By acquiring Dermavant, Organon gets Vtama, a drug approved for treating plaque psoriasis. An FDA decision for the topical cream in atopic dermatitis is expected by the end of 2024. The post Organon Gets More Skin in the Game by Acquiring Roivant’s Dermatology Subsidiary appeared first on MedCity News.
More than three-quarters of American adults didn’t get a covid shot last season, a figure that health care experts warn could rise this year amid new U.S. government recommendations. The covid vaccine was initially popular. About 75% of Americans had received at least one dose of the first versions of the vaccine by early 2022,…
All of us can see glaring issues with the healthcare system that need to be addressed — but system-level change is hard. The leap to VBC isn’t easy, but the results are undeniable. The post Reclaiming the Joy of Medicine: How Value-Based Care Can Restore Physician Purpose appeared first on MedCity News.
El “One Big Beautiful Bill” del presidente Donald Trump recorta el gasto federal en los mercados de Medicaid y la Ley de Cuidado de Salud a Bajo precio (ACA) en aproximadamente $1.000 millones a lo largo de una década, según la Oficina de Presupuesto del Congreso (CBO), una entidad no partidista. Esto amenaza la salud…
The decline in cognitive health, especially that leading to Alzheimer’s and other brain diseases, is one of the most feared conditions by patients and their families. It’s also one of the most expensive. But if we can predict it early there are things we can do to prevent or ameliorate it. The issue has been…
Flagship Pioneering-founded Generate Biomedicines aims to offer less frequent injections compared to a blockbuster asthma drug from partners Amgen and AstraZeneca. Generate’s drug comes from a “programable biology” platform technology that uses AI and machine learning to design proteins with desirable properties. The post Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe…